Bibliographic record
Abstract
わが国における小児鼻アレルギー診療の中心は，現状では薬物療法である。しかし，薬物療法はあくまでも対症療法であり，鼻アレルギーの根本的な治療になるわけではない。アレルゲン免疫療法（AIT）は，唯一根治の可能性のある治療法であり，古くより皮下免疫療法（SCIT）が行われてきたが，稀にアナフィラキシーなどの重篤な副作用があり，日本では普及してこなかった。より安全性の高い舌下免疫療法（SLIT）は，欧州を中心に普及し，2014年よりわが国でもスギ花粉舌下液の販売が開始された。その後，ダニ舌下錠が登場し，世界に先駆けてわが国でのみ小児に対する適応が取得された。SLITを含めたAITは小児に対して有効な治療法であり，さらなる普及が期待される。
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.001 | 0.002 |
| Insufficient payload (model declined to judge) | 0.071 | 0.012 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; both teacher heads agree on what is shown here.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".